Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 hoe 21pH insulin and external pumps using lispro in type 1 diabetic patients: A pilot study

Diabetes and Metabolism

Volumn 28, Issue 2, 2002, Pages 133-137

  Catargi, B ^a   Meyer, Laurent ^a   Melki, V ^a   Renard, E ^a   Jeandidier, N ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

CSII; Implantable insulin pump; Insulin analog; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN LISPRO; NEUTRAL INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; TREATMENT OUTCOME;

AGE OF ONSET; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 0036241609     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes
3. Implementation of treatment protocols in the Diabetes Control and Complications Trial
4. Subcutaneous insulin infusion: Change in basal infusion rate has no immediate effect on insulin absorption rate
5. Insulin lispro in CSII: Results of a double-blind crossover study
6. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
7. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients
8. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump
9. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study
10. Symmetrization of the blood glucose measurement scale and its applications
11. Assessment of risk for severe hypoglycemia among adults with IDDM: Validation of the low blood glucose index
12. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: A randomized study
13. Determination of portal insulin absorption from peritoneum via novel non isotopic method
14. Insulin kinetics in type 1 diabetic patients treated with continuous intraperitoneal insulin infusion: Influence of anti insulin antibodies
15. French multicentre experience of implantable insulin pumps
16. Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps
17. Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility
18. Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin
19. Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump: The EVADIAC experience
20. How to measure glycemic instability?
21. Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices
22. A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type 1 diabetes
23. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycemai in type 1 diabetic patients
24. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data